Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancement
- 31 July 1992
- journal article
- research article
- Published by Elsevier BV in Cytokine
- Vol. 4 (4), 269-280
- https://doi.org/10.1016/1043-4666(92)90067-2
Abstract
The effect of commonly used food antioxidants on recombinant tumor necrosis factor α (rTNF-α)-induced cytotoxicity, growth enhancement and adhesion has been evaluated. Butylated hydroxyanisole (BHA) and 4-hydroxymethyl-2,6-di-t-butylphenol (HBP) were the only two of nine antioxidants that completely inhibited rTNF-α-induced cytotoxicity in L929 and WEHI 164 fibrosarcoma cells. Ethoxyquin, propyl gallate and butylated hydroquinone only partially inhibited rTNF-α-induced cytotoxicity, while the antioxidants butylated hydroxytoluene (BHT), α-tocopherol, ascorbic acid and thiodipropionic acid had minimal effects. The only difference between the molecular structure of the efficient HBP and the non-efficient BHT, is a hydroxymethyl group instead of a hydroxyl group on the phenolic ring. Neither BHA nor BHT inhibited the activation of NF ϰB after 10 or 60 min challenge with rTNF-α in L929 cells. BHA also inhibited rTNF-α-induced, but not rIL-1β-induced growth enhancement in FS-4 fibroblasts. Further, BHA blocked both rTNF-α-induced and rIL-1β-induced prostaglandin E2 synthesis in FS-4 fibroblasts. BHA inhibited the rTNF-α-induced release of arachidonic acid in both FS-4 and L929 cells, suggesting that BHA inhibits cellular phospholipase(s). Neither α-tocopherol nor BHA inhibited rTNF-α-induced adhesiveness of human endothelial cells. The results indicate that BHA is a specific and potent inhibitor of rTNF-α- and rTNF-β-induced cytotoxicity, as well as of rTNF-α-induced growth enhancement.Keywords
This publication has 27 references indexed in Scilit:
- Cytokine regulation of interleukin 6 production by human endothelial cellsCellular Immunology, 1989
- Interleukin-one induced inositol phospholipid breakdown in murine macrophages: Possible mechanism of receptor activationBiochemical and Biophysical Research Communications, 1988
- Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolismBiochemical and Biophysical Research Communications, 1987
- Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.The Journal of Experimental Medicine, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.The Journal of Experimental Medicine, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Factors influencing endothelial cell proliferation in vitroJournal of Cellular Physiology, 1978
- Inhibition of the mono-oxygenase system by butylated hydroxyanisole and butylated hydroxytolueneLife Sciences, 1974
- The inhibition of the fatty acid oxygenase of sheep vesicular gland by antioxidantsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973